SearcharxivSearch

arXiv subjects

Troy Day

Publications and source records attributed to Troy Day.

8 recordsLinked to original sources

Regional factors determine the feasibility of an elimination strategy

We provide an explicit mathematical characterization of regional characteristics and the resulting epidemiology to evaluate whether elimination or suppression is feasible using targeted measures, such as case isolation and contact tracing. We derive an epidemic model where community members can be infected by either travellers or other community members, and with constraints on the public health resources available to support isolation of arriving travellers and infected community members. We prove that the optimal controls are to immediately implement public health measures at their maximum levels. We find that elimination or suppression strategies are feasible with targeted measures if public health capacity is high, the transmission rate is low, or if the arrival rate of infected travellers is low. Our results illustrate that a particular country that implemented a mitigation strategy during the pandemic may not necessarily have achieved better outcomes if it had instead implemented elimination because elimination may not have been feasible in countries with low public health capacity to support control measures, high transmission rates, or high traveller arrival rates. Combinations of regional characteristics determine whether an elimination, suppression or mitigation strategy without resurgence is feasible. We find that regions with the low traveller arrival rates and the capacity to implement and enforce isolation or quarantine of arriving travellers are less likely to exceed their capacity to contact trace and isolate community members. Travel measures prevent only a small number of community infections via their direct effect, but indirectly, by protecting contact tracing capacity, travel measures can prevent epidemic resurgence and substantially reduce the number of people infected during a pandemic before a vaccine or therapy is developed.

math.OC

Analysis of persistence thresholds for a nonlocal PDE--ODE model of bacterial persister cells

Within many bacterial colonies, persister cells exist as a subpopulation that is tolerant to antibiotics and other stressors, yet not genetically distinct from the rest of the colony. A recent study has proposed epigenetic inheritance as a mechanism that leads to the presence of persister cells. We analyze a nonlocal PDE--ODE model introduced in that study to describe the epigenetic inheritance process and establish its mathematical well-posedness, including existence, uniqueness, and nonnegativity of solutions. We identify a sharp parameter threshold delineating extinction from persistence of the colony: below this threshold the washout equilibrium is globally asymptotically stable, while above it a unique positive equilibrium exists and the population is weakly persistent. Notably, this threshold is independent of the internal community structure.

math.AP

The gig economy during an epidemic: coupling disease transmission with labour market dynamics

The gig economy has grown significantly in recent years, driven by the emergence of various facilitating platforms. Triggering substantial shifts to labour markets across the world, the COVID-19 pandemic has accelerated this growth. To understand the crucial role of such an epidemic on the dynamics of labour markets of both formal and gig economies, we develop and investigate a model that couples disease transmission and a search and match framework of unemployment. We find that epidemics increase gig economy employment at the expense of formal economy employment, and can increase the total long term unemployment. In the short run, large sharp fluctuations in labour market tightness and unemployment can occur, while in the long run, employment is reduced under an endemic disease equilibrium. We analyze a public policies that increase unemployment benefits or provide benefits to gig workers to mitigate these effects, and evaluate their trade-offs in mitigating disease burden and labour market disruptions.

econ.TH

Democratising Artificial Intelligence for Pandemic Preparedness and Global Governance in Latin American and Caribbean Countries

Infectious diseases, transmitted directly or indirectly, are among the leading causes of epidemics and pandemics. Consequently, several open challenges exist in predicting epidemic outbreaks, detecting variants, tracing contacts, discovering new drugs, and fighting misinformation. Artificial Intelligence (AI) can provide tools to deal with these scenarios, demonstrating promising results in the fight against the COVID-19 pandemic. AI is becoming increasingly integrated into various aspects of society. However, ensuring that AI benefits are distributed equitably and that they are used responsibly is crucial. Multiple countries are creating regulations to address these concerns, but the borderless nature of AI requires global cooperation to define regulatory and guideline consensus. Considering this, The Global South AI for Pandemic & Epidemic Preparedness & Response Network (AI4PEP) has developed an initiative comprising 16 projects across 16 countries in the Global South, seeking to strengthen equitable and responsive public health systems that leverage Southern-led responsible AI solutions to improve prevention, preparedness, and response to emerging and re-emerging infectious disease outbreaks. This opinion introduces our branches in Latin American and Caribbean (LAC) countries and discusses AI governance in LAC in the light of biotechnology. Our network in LAC has high potential to help fight infectious diseases, particularly in low- and middle-income countries, generating opportunities for the widespread use of AI techniques to improve the health and well-being of their communities.

cs.AI

The evolutionary epidemiology of pathogens during vaccination campaigns

With the unprecedented global vaccination campaign against SARS-CoV-2 attention has now turned to the potential impact of this large-scale intervention on the evolution of the virus. In this perspective we summarize what is currently known about evolution in the context of vaccination from research on other pathogen species, with an eye towards the future evolution of SARS-CoV-2.

q-bio.PE

Pathogen evolution: slow and steady spreads the best

The theory of life history evolution provides a powerful framework to understand the evolutionary dynamics of pathogens in both epidemic and endemic situations. This framework, however, relies on the assumption that pathogen populations are very large and that one can neglect the effects of demographic stochasticity. Here we expand the theory of life history evolution to account for the effects of finite population size on the evolution of pathogen virulence. We show that demographic stochasticity introduces additional evolutionary forces that can qualitatively affect the dynamics and the evolutionary outcome. We discuss the importance of the shape of pathogen fitness landscape and host heterogeneity on the balance between mutation, selection and genetic drift. In particular, we discuss scenarios where finite population size can dramatically affect classical predictions of deterministic models. This analysis reconciles Adaptive Dynamics with population genetics in finite populations and thus provides a new theoretical toolbox to study life-history evolution in realistic ecological scenarios.

q-bio.PE

Slowing evolution is more effective than enhancing drug development for managing resistance

Drug resistance is a serious public health problem that threatens to thwart our ability to treat many infectious diseases. Repeatedly, the introduction of new drugs has been followed by the evolution of resistance. In principle there are two ways to address this problem: (i) enhancing drug development, and (ii) slowing drug resistance. We present data and a modeling approach based on queueing theory that explores how interventions aimed at these two facets affect the ability of the entire drug supply system to provide service. Analytical and simulation-based results show that, all else equal, slowing the evolution of drug resistance is more effective at ensuring an adequate supply of effective drugs than is enhancing the rate at which new drugs are developed. This lends support to the idea that evolution management is not only a significant component of the solution to the problem of drug resistance, but may in fact be the most important component.

q-bio.PE

Computability, Gödel's Incompleteness Theorem, and an inherent limit on the predictability of evolution

The process of evolutionary diversification unfolds in a vast genotypic space of potential outcomes. During the past century there have been remarkable advances in the development of theory for this diversification, and the theory's success rests, in part, on the scope of its applicability. A great deal of this theory focuses on a relatively small subset of the space of potential genotypes, chosen largely based on historical or contemporary patterns, and then predicts the evolutionary dynamics within this pre-defined set. To what extent can such an approach be pushed to a broader perspective that accounts for the potential open-endedness of evolutionary diversification? There have been a number of significant theoretical developments along these lines but the question of how far such theory can be pushed has not been addressed. Here a theorem is proven demonstrating that, because of the digital nature of inheritance, there are inherent limits on the kinds of questions that can be answered using such an approach. In particular, even in extremely simple evolutionary systems a complete theory accounting for the potential open-endedness of evolution is unattainable unless evolution is progressive. The theorem is closely related to Gödel's Incompleteness Theorem and to the Halting Problem from computability theory.

q-bio.PE